tiprankstipranks
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market
RVPH
Reviva Pharmaceuticals Holdings
RESEARCH TOOLSreports

Reviva Pharmaceuticals Holdings (RVPH) Income Statement

1,207 Followers

Reviva Pharmaceuticals Holdings Income Statement

Last quarter (Q4 2025), Reviva Pharmaceuticals Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Reviva Pharmaceuticals Holdings's net income was $-19.86T. See Reviva Pharmaceuticals Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 20.20T$ 30.80M$ 39.50M$ 24.31M$ 10.10M
Depreciation and Amortization
$ 0.00$ 30.80M$ 39.50M$ 194.71K$ 591.00
EBITDA
$ -20.20T$ -29.88M$ -39.21M$ -24.11M$ -10.10M
Operating Income
$ -20.20T$ -30.80M$ -39.50M$ -24.31M$ -10.10M
Other Income/Expenses
$ 354.02B$ 899.60K$ 259.75K$ -11.91K$ 1.59M
Pretax Income
$ -19.85T$ -29.90M$ -39.24M$ -24.32M$ -8.52M
Net Income
$ -19.86T$ -29.92M$ -39.26M$ -24.34M$ -8.52M
Per Share Metrics
Basic EPS
$ -5.48$ -18.00$ -33.00$ -29.00$ -11.60
Diluted EPS
$ -5.48$ -18.00$ -33.00$ -29.00$ -11.60
Weighted Average Shares Outstanding
 3.63M 1.66M 1.19M 975.82K 739.54K
Weighted Average Shares Outstanding (Diluted)
 3.63M 1.66M 1.19M 975.82K 739.54K
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History